Daily Stock Opinions and Ratings

Opinions

John Sinkins, CFAForest LaboratoriesFRXTOP PICKSep 13, 2004

Had dropped because of concerns about teens using their anti-depressant. A good price.

John Sinkins, CFA

Owned

Unlock Rating

$42.51

Stock price when the opinion was issued

$12.00

As of Jun 25, 2021. Market Open.

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Stock price has been cut in half since March/04 because of their depression drug which is coming off patent. Creating their own generic drug. Great company. Juggernaut sales force. Has about $4 of cash. Has a product ramp in alzheimers.

BUY

Buy, stick away and don't look at it for quite awhile. Costs are low on R & D because they tend to buy compounds that have already been researched. Not cheap.

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

John Sinkins, CFAForest LaboratoriesFRXTOP PICKSep 13, 2004

You might be interested:

Forest Laboratories(FRX)

Forest Laboratories(FRX)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals